Drug Trial Radar · NCT05843383
Comparison of Ciprofol-based and Propofol-based Total Intravenous Anesthesia on Postoperative Quality of Recovery
Last checked: Nov 19, 2026Latest source record: Apr 9, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
280
Planned (sponsor's estimate)
Start
May 16, 2023
Primary completion
Dec 1, 2024
Study completion Dec 1, 2024
Sponsor
- Lead sponsor
- Xijing HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- May 6, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Ciprofol is a novel 2,6-disubstituted phenol derivatives and is proved have much higher potency and tighter binding toward ɣ-aminobutyric acid type A (GABAA) receptor while maintaining a fast on-set and recovery time compared to propofol. Except lower incidence of hypotension and respiratory depression, it has no injection pain and infusion syndrome compared with propofol. There is no study to investigate overall postoperative functional recovery in patients receiving total intravenous anesthesia (TIVA) using ciprofol yet. However, according to study, early quality of recovery according to QoR-15 score is associated with one-month postoperative complications after elective surgery. Therefore, the purpose of this study is to determine whether there is any difference in the quality of postoperative recovery between ciprofol-based and propofol-based TIVA in elderly patients undergoing gastrointestinal surgery. The QoR-15 questionnaire score, pain, nausea/vomiting, and the frequency of complications are evaluated and compared between the two groups.
Conditions
- Anesthetics, Intravenous
- Postoperative Complications
- Hypnotics and Sedatives
- Postoperative Recovery
Interventions
CiprofolDrug
Ciprofol group will be started and maintained total intravenous anesthesia with ciprofol and remifentanil
PropofolDrug
Propofol group will be started and maintained total intravenous anesthesia with propofol and remifentanil
Primary outcomes
What the sponsor says the trial is designed to measure.
- Quality of Recovery(QoR)-15 questionnaire score at postoperative day 1Time frame: Postoperative day 1
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Xijing Hospital
Xi'an, Shaanxi, China · Not yet recruiting
Xijing Hospital
Xi'an, Shaanxi, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.